We are live on ! Find out more
EAM

EFG Asset Management Portfolio holdings

AUM $773M
1-Year Est. Return 40.1%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+40.1%
3 Year Est. Return
+211.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$732M
AUM Growth
+$135M
Cap. Flow
+$114M
Cap. Flow %
15.53%
Top 10 Hldgs %
20.87%
Holding
199
New
12
Increased
128
Reduced
34
Closed
25

Top Buys

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$4.31M
2
INSM icon
Insmed
INSM
+$4.09M
3
PLTR icon
Palantir
PLTR
+$3.75M
4
BPMC
Blueprint Medicines
BPMC
+$3.72M
5
NVMI
Nova
NVMI
+$3.68M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.43M
2
TMDX icon
Transmedics
TMDX
+$3.25M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$3.04M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$2.94M
5
LEGN icon
Legend Biotech
LEGN
+$2.88M

Sector Composition

Rank Sector Weight
1 Technology 29.68%
2 Healthcare 25.52%
3 Industrials 12.74%
4 Consumer Discretionary 11.74%
5 Financials 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZS icon
151
Zscaler
ZS
$24.5B
$2.12M 0.29%
11,724
-496
-4% -$96K
LEN icon
152
Lennar Class A
LEN
$19.8B
$2.1M 0.29%
15,883
+1,417
+10% +$230K
UFPT icon
153
UFP Technologies
UFPT
$1.97B
$2.09M 0.29%
8,537
+3,155
+59% +$918K
GRMN
154
Garmin
GRMN
$56.7B
$2.08M 0.28%
10,066
+4,034
+67% +$791K
CPRT icon
155
Copart
CPRT
$27B
$2.04M 0.28%
35,471
-1,446
-4% -$82.4K
PUBM icon
156
PubMatic
PUBM
$585M
$1.96M 0.27%
133,756
+49,133
+58% +$761K
SYRE icon
157
Spyre Therapeutics
SYRE
$8.54B
$1.93M 0.26%
82,818
+30,608
+59% +$898K
LEVI icon
158
Levi Strauss
LEVI
$9.44B
$1.88M 0.26%
108,854
+14,006
+15% +$248K
NXPI icon
159
NXP Semiconductors
NXPI
$57.8B
$1.87M 0.26%
9,000
+737
+9% +$168K
ONC
160
BeOne Medicines Ltd
ONC
$32.8B
$1.85M 0.25%
9,986
-3,489
-26% -$713K
IMVT icon
161
Immunovant
IMVT
$7.93B
$1.83M 0.25%
73,981
+163
+0.2% +$4.62K
RCKT icon
162
Rocket Pharmaceuticals
RCKT
$340M
$1.83M 0.25%
145,629
-98,791
-40% -$1.49M
SNOW icon
163
Snowflake
SNOW
$102B
$1.83M 0.25%
+11,840
New +$1.67M
NBIX icon
164
Neurocrine Biosciences
NBIX
$16.8B
$1.82M 0.25%
13,321
-14,190
-52% -$1.76M
MSCI icon
165
MSCI
MSCI
$41.6B
$1.75M 0.24%
2,921
+1,062
+57% +$637K
CRUS icon
166
Cirrus Logic
CRUS
$6.53B
$1.74M 0.24%
17,493
+6,459
+59% +$710K
FN icon
167
Fabrinet
FN
$15.6B
$1.73M 0.24%
+7,849
New +$1.89M
CRL icon
168
Charles River Laboratories
CRL
$11.2B
$1.65M 0.23%
8,959
-2,845
-24% -$548K
GAP
169
The Gap Inc
GAP
$7.23B
$1.65M 0.23%
69,728
+26,046
+60% +$594K
COIN icon
170
Coinbase
COIN
$38.5B
$1.5M 0.2%
+6,042
New +$1.53M
APLS
171
DELISTED
Apellis Pharmaceuticals
APLS
$1.38M 0.19%
43,157
+10,087
+31% +$303K
PIPR icon
172
Piper Sandler
PIPR
$5.12B
$1.25M 0.17%
+16,572
New +$1.29M
SPXC icon
173
SPX Corp
SPXC
$11B
$1.24M 0.17%
+8,546
New +$1.38M
EWTX icon
174
Edgewise Therapeutics
EWTX
$4.13B
$1.1M 0.15%
+41,338
New +$1.32M
A icon
175
Agilent Technologies
A
$39.1B
– –
-19,352
Closed -$2.87M
4 5 6
7
8

Similar funds

HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
WA
Wealthstream Advisors New York $661M AUM 18% 1-Year Est. Return
PAS
Point72 Asia (Singapore) Singapore $646M AUM 35.24% 1-Year Est. Return
NSEDCP
NJ State Employees Deferred Compensation Plan Trenton, New Jersey $906M AUM 24.85% 1-Year Est. Return
RAM
RedJay Asset Management Toronto, Ontario, Canada $639M AUM 21.05% 1-Year Est. Return

EFG Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, EFG Asset Management held 199 positions worth $732M, up 23% from $598M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

EFG Asset Management deployed $114M of net new capital in Q4 2024, opening 12 new positions and adding to 128 existing holdings. Its largest new stake was Nova: 19,152 shares worth $3.77M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Fair Isaac, an estimated $1.9M trimmed.

  • EFG Asset Management's largest Q4 2024 buy was Nova: 19,152 shares worth $3.77M.
  • EFG Asset Management added most to Glaukos in Q4 2024, an estimated $4.31M increase.
  • EFG Asset Management's biggest Q4 2024 reduction was Fair Isaac, cutting an estimated $1.9M.
  • EFG Asset Management fully exited Tesla in Q4 2024, selling an estimated $4.43M.
  • EFG Asset Management's ten largest holdings make up 21% of its $732M portfolio in Q4 2024.
  • EFG Asset Management opened 12 new positions and closed 25 in Q4 2024.
  • EFG Asset Management's portfolio value rose 23% quarter-over-quarter to $732M.

Based on EFG Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.